SSGJ-707
Product Specifications
Target
PD-1/PD-L1, VEGFR
Related Pathways
Apoptosis, Tyrosine Kinase/Adaptors, Angiogenesis, Immunology/Inflammation, Cell Cycle/Checkpoint
Bioactivity
SSGJ-707 is a bispecific recombinant humanized IgG4 monoclonal antibody inhibitor that targets PD-1 and VEGF. It is applicable in cancer research, particularly for advanced non-small cell lung cancer (NSCLC) and recurrent endometrial cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB3076-500 1x 500 µL
APC / Adenomatous Polyposis Coli / FAP (Tumor Suppressor) (ALi 12-28), 0.2mg/mL
Sign In for Pricing
View Details 
BNC682730-100 1x 100 µL
Human IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 